Should I buy, hold, or sell CDRE stock right now?

Cadre Holdings Inc. (CDRE) currently earns a Roarable Rating of C (Hold — HOLD) with 62/100 RQD Confidence. Solid 42.5% gross margin (11% return on capital), mixed timing at 30x P/E—hold if owned, no rush to chase.

What is CDRE's 12-month price target and RQD AI Jury consensus?

CDRE's 12-month base price target is $32.08 (range $25.02 to $51.2), backed by transparent SEC XBRL cash-flow, Form 4 insider, and CBOE options flow analysis.

Stock Ratings / Health Care / CDRE

ENOV (38) ESTA (26) AVR (22) ZJYL (46) ⌘ Pro Terminal →

Cadre Holdings Inc. (CDRE) — RQD Stock Rating Cockpit

$31.51 +3.79% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $31.67

Cadre Holdings Inc. (CDRE) carries a Roarable Rating of C (Hold) with 62/100 RQD Confidence. The composite score sits in the neutral Hold band (59–69), meaning current holders don’t need to panic-sell while prospective buyers can wait for a move into the 70+ Buy zone.

ROARABLE C • HOLD / WATCH Cap $1.30B

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on CDRE Below — or Connect Your Own ChatGPT / Claude

🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is CDRE stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

▼

As of 2026-11-03, Cadre Holdings Inc. (NYSE: CDRE) is rated C (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 62/100 at a spot price of $31.51 (+3.79% 1D, market cap $1.30B). Pillar breakdown: Fundamental Cash Engine 16/20, Institutional 13F & Options Flow 10/20, SEC Balance-Sheet Forensics 15/20, FRED Macro Regime Fit 7/20, and Executive Insider Alignment 14/20. Across 1015 tracked Health Care issuers, CDRE ranks #150 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief

🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does CDRE compare to ENOV and ESTA in the Health Care sector?

▼

Within the Health Care sector (Industrial Specialties), CDRE carries a Roarable C (62/100 RQD), trailing P/E of 30.2x, gross margin of 42.5%, and ROIC of 11.0%. By comparison, ENOV (Enovis Corporation) holds a D- grade (38/100 RQD, P/E N/A, ROIC -32.7%, cap $1.15B) and ESTA (Establishment Labs Holdings Inc.) posts a E grade (26/100 RQD, P/E N/A, ROIC -15.8%, cap $1.86B). Among the 5-stock peer group, CDRE leads on earnings multiple (30.2x) while CDRE leads on capital efficiency (11.0% ROIC).

✓ Pre-computed one-to-many AI Quant brief

🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for CDRE?

▼

Per CDRE's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001860543), Cadre Holdings Inc. generated $610.3M in revenue (+7.5% YoY), $44.1M in net income, and $56.8M in free cash flow against $770.0M in total assets and $291.0M in total debt. Key quantitative strengths: Strong cash generator (42.5% gross margin)—profits are backed by real money, not accounting tricks. Primary risk factors monitored: Sensitive to high interest rates and tighter Federal Reserve market liquidity. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief

🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $31.66 (+0.49%)🧬 Cannibal Buyback (-1.80% YoY Shares)⚙️ Cash Engine: 16/20 (B+) • 9.3% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record: Scores of 62/100 (C) historically posted market-perform odds over rolling 90-day windows (+0.7% avg 90D alpha vs SPY • 54.3% hit rate — wait for RQD ≥ 70 breakout).

Audit Bucket Track Record →

RQD QUANT TACHOMETERHOLD / WATCH • C

2-of-3 JEV AI Jury Bullish

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw C+ · Rk D+

Each axis scored 0–20

12M PRICE TARGET CONE+1.8% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for CDRE)Realized 20D OHLCV Swing Band: ±8.8%

Deterministic 5-Pillar Attribution (62/100 Composite)

🔍 WHY CDRE SCORES 62/100 (C) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: Cash Engine Quality+16/20 pts (26% of score)

SEC XBRL FY 2025 (10-K): 9.3% FCF Margin ($56.8M FCF) & 42.5% Gross Margin

▲ #2 Bullish Driver: SEC 10-K Forensic Risk+15/20 pts (24% of score)

Altman Z-Score 3.32 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 9/9

▼ #1 Drag / Risk Factor: Macro Regime Fit7/20 pts (-13 pt drag)

Macro rate sensitivity & RSI-14 (62.1) create a -13 pt regime headwind

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade C-$26.15+3.4% Next Q

Q2 (-2Q)

Grade C$27.05+13.3% Next Q

Q3 (-1Q)

Grade C$30.64+2.8% Next Q

Current

Grade C$31.51+0.7% Hist 90D α

Trajectory: C- (54) → C (62)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

⚔️ Adversarial Opposing Case: Why the CDRE Bull Thesis Could Fail

Gideon Ashmere Forensic Desk →

Even with a 62/100 (C) score, CDRE faces multiple-compression risk if 30.2x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Sensitive to high interest rates and tighter Federal Reserve market liquidity.

⚠️ Forensic Kill-Switch #2

Dilution & Margin Drag: Cannibal Buyback (-1.80% YoY Shares) — any gross margin slip below 40.0% triggers an automatic RQD downgrade.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($27.84) or 200D SMA ($32.09) invalidates the momentum regime and cuts Target Base ($32.08) toward Bear Floor ($25.02).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $CDRE• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “CDRE Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”

YES 62%NO 38%Trade / Inspect Odds →

RSI-14 MOMENTUMBULLISH MOMENTUM

62.130 Oversold · 70 Hot

ALTMAN-Z SHIELDFORTRESS SAFE (>3.0)

3.32>3.0 Fortress Safe

PIOTROSKI F-SCOREHIGH QUALITY (7–9)

9 / 99-Pt Accounting

52-WEEK LASER RANGE30% OF RANGE

L: $24$31.51H: $49

1. Money & Cash Health● HEALTHY

Are profits real cash in the bank?

Real cash coming in backs up reported profits (42.5% gross margin and healthy balance-sheet cushion).

Factor Grade: B+RQD 16 / 20

2. Big Money & Insiders● NEUTRAL

Are whales & executives buying or selling?

Big funds and company insiders are mostly holding steady without aggressive buying or panic selling.

Factor Grade: C-RQD 24 / 40

3. Hidden Risks & Market Weather● WATCH

SEC fine-print scan & interest-rate fit

No major SEC filing blowups, though current interest rates and Fed liquidity call for normal position sizing.

Factor Grade: D+RQD 22 / 40

MULTI-MODEL JEV QUANT JURY DELIBERATION

2-of-3 JEV AI Jury Bullish on CDRE

Cash & Moat Bull AI

ROIC & Free Cash Flow Model

BULLISH (80)

11.0% ROIC with 42.5% gross margin and 4.27% FCF yield.

SEC Forensic Auditor AI

10-K Accruals & Altman-Z Guard

BULLISH (75)

Altman-Z 3.32 and Piotroski 9/9 pass balance-sheet audit.

Whale & Macro Hawk AI

Options Skew, 13F & Fed NetLiq

NEUTRAL (52)

24/40 institutional & smart-money positioning score with 7/20 macro alignment.

Bull Case: Why Buyers Like CDRE

✓Strong cash generator (42.5% gross margin)—profits are backed by real money, not accounting tricks.
✓Company leadership has skin in the game with net positive insider conviction.
✓Clean SEC annual filing review with no major hidden accounting time-bombs.

Bear Case: What Could Go Wrong

!Sensitive to high interest rates and tighter Federal Reserve market liquidity.

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Quantitative Research Desk

Scheduled RQD Strong Buys & Whale Accumulation Briefing (CDRE Tape Review)

✓Breakdown of the highest-scoring RQD Green-Light breakouts across our 5,200+ rated universe
✓Forensic Red-Light accounting & dilution traps to review on your watchlist
✓Includes downloadable .ics calendar invite & nightly RQD rating-change email alerts

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

CDRE // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +7.25%📐 HORIZONTAL RANGE

2026-11-03O $31.10H $31.51L $30.36C $31.51VOL 320.5K

RES: $43.09SUP: $22.84SMA50: $27.84SMA200: $32.09

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

CDRE Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 CDRE Butterfly Map → + Track CDRE →

Share Count & Dilution Monitor

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle

23.3%/yr Implied 5Y Growth

vs. +7.5% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger

No active Ellis Vennor swing setup published on CDRE today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for CDRE. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for CDRE today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (CDRE)

Health Care Rank #150 of 1015 ⚔️ ENOV vs CDRE Full Matrix →

1. Head-to-Head Health Care Peer Comparison (CDRE vs. ENOV, ESTA, AVR, ZJYL)

Industry: Industrial Specialties (55 Tracked Issuers)

Across 1015 tracked Health Care securities in the Roarable RQD universe, Cadre Holdings Inc. (CDRE) ranks #150 by composite RQD confidence (62/100, grade C) and #323 by equity capitalization ($1.30B). Within this direct 5-issuer industry benchmark cohort, CDRE leads on earnings valuation at 30.2x trailing P/E, while CDRE leads on capital efficiency and profitability with 11.0% ROIC and 42.5% gross margin. CDRE currently leads its immediate peer cohort in composite quantitative strength at 62/100 (C).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
CDRE ACTIVE Cadre Holdings Inc.	C	62/100	30.2x	42.5%	11.0%	+3.79%	$1.30B	Benchmark Subject
ENOV Enovis Corporation	D-	38/100	—	59.8%	-32.7%	+3.57%	$1.15B	/enov-vs-cdre →
ESTA Establishment Labs Holdings Inc.	E	26/100	—	69.3%	-15.8%	-2.22%	$1.86B	/esta-vs-cdre →
AVR Anteris Technologies Global Corp.	E	22/100	—	70.3%	-35.0%	-8.40%	$615.2M	/avr-vs-cdre →
ZJYL JIN MEDICAL INTERNATIONAL LTD. (Class A)	D	46/100	—	29.2%	—	-6.38%	$371.8M	/zjyl-vs-cdre →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001860543 ↗

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Cadre Holdings Inc. (CDRE) reported GAAP revenue of $610.3M (+7.5% vs. FY2024 revenue of $567.6M , and +26.5% cumulative change since FY2023) , GAAP net income of $44.1M, operating cash flow of $63.7M, and free cash flow of $56.8M (+117.7% YoY). On the balance sheet, CDRE closed FY2025 with $770.0M in total assets against $291.0M in total debt (Altman Z-Score: 3.32, Piotroski F-Score: 9/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$610.3M	$44.1M	$63.7M	$56.8M	$770.0M	$291.0M
FY2024 (FY)	2024-12-31	$567.6M	$36.1M	$31.8M	$26.1M	$652.7M	$211.8M
FY2023 (FY)	2023-12-31	$482.5M	$38.6M	$73.2M	$73.2M	—	—

3. CDRE Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is CDRE stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

How does CDRE compare to ENOV and ESTA in the Health Care sector?

What are the biggest fundamental strengths and SEC risk factors for CDRE?

Where is CDRE trading relative to its 50-day, 200-day, and 52-week technical levels?

CDRE last traded at $31.51 (+3.79% on volume of 559,274 shares), positioning the stock +13.18% above its 50-day simple moving average ($27.84) and -1.81% below its 200-day simple moving average ($32.09). Across its 52-week range of $24.07 to $48.76, CDRE sits at the 30.1% percentile with a 14-day RSI of 62.1 (BULLISH MOMENTUM) and an implied next-earnings move of ±8.8% ($28.74 to $34.28).

Direct Sub-Reports: CDRE RQD Cockpit CDRE 12M Forecast CDRE Earnings & Move CDRE Dividends & DRIP CDRE Insiders & 13F CDRE Whale Options CDRE Profit Sankey CDRE News & Why

ROARABLE RATING BRIEF • RQD 62/100 (C) ✓ SEC XBRL & RQD VERIFIED

CDRE — Cadre Holdings Inc.: What the Facts Mean to a Prospective Investor

Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit

Updated: 2025-12-31

1. Roarable Rating Brief: What This Means to a Prospective Investor

Cadre Holdings Inc. (CDRE) earns a live Roarable RQD composite score of 62/100, corresponding to a C letter grade (Roarable Hold) at a spot price of $31.51 (+3.79% 1D, market capitalization $1.30B).

Fundamental Cash Engine (16/20): Anchored by return on invested capital (ROIC) of 11.0%, gross margin of 42.5%, operating margin of 11.0%, and free cash flow yield of 4.27%.
Whale 13F & Options Flow (10/20) + Insider Conviction (14/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
Macro Regime Fit (7/20) + Forensic Balance Sheet (15/20): Incorporates a 1.00x equity beta, Altman Z-Score of 3.32, Piotroski F-Score of 9/9, and Debt/Equity of 0.92x.

2. Business Model, Unit Margins & SEC Financial Trajectory

Cadre Holdings Inc. (CDRE) is a NYSE-listed issuer classified under the Health Care sector and the Industrial Specialties industry. The company's specific products, customers, and revenue model are — The market data does report a gross margin of 42.5%, an operating margin of 11%, and a net margin of 7.2%, which describe the profitability structure of its reported revenue.

In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2025-12-31), Cadre Holdings Inc. (CDRE) reported $610.3M in annual revenue (up from $567.6M in FY2024, +7.5% YoY) and $44.1M in GAAP net income. Over the multi-year SEC filing window from FY2023 ($482.5M revenue, $38.6M net income) through FY2025, CDRE scaled operating cash flow to $63.7M and free cash flow to $56.8M, backed by $770.0M in total assets against $291.0M in total debt.

3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff

🐂 Primary Bull Case (C • RQD 62/100): Strong cash generator (42.5% gross margin)—profits are backed by real money, not accounting tricks. Company leadership has skin in the game with net positive insider conviction. With Fundamental Cash Engine at 16/20 and Institutional Whale Flow at 10/20, sustained execution supports upside toward the upper end of the $24.07 – $48.76 52-week range.
🐻 Primary Bear Case & Valuation Risk: Sensitive to high interest rates and tighter Federal Reserve market liquidity. Investors must weigh 30.2x trailing P/E and 20.5x EV/EBITDA against 11.0% operating margins and a 1.00x macro beta.

4. 2nd-Order Butterfly Ripples & Key Questions to Watch

Operating in Industrial Specialties (Health Care), CDRE carries a macro regime beta of 1.00 and gross margin of 42.5%.

Key Question #1: Can CDRE sustain or expand its 11.0% operating margin and 11.0% ROIC against Industrial Specialties peers over the next 4 quarters?
Key Question #2: Following FY2025 revenue of $610.3M and free cash flow of $56.8M, how will capital allocation balance growth reinvestment against $291.0M in total debt?
Key Question #3: How sensitive is CDRE's 28.1x forward P/E multiple to Health Care capital spending cycles and macro interest-rate shifts (Beta 1.00x)?

CDRE Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Cadre Holdings Inc. (CDRE) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to CDRE Debate Forum (3) ↓

🟢 CATALYST Yahoo Finance • 21h ago

Cadre (CDRE) Stock Could Be A Bargain On Cash Flow

Yahoo Finance report covering Cadre Holdings Inc. (CDRE) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🔴 RISK WATCH Seeking Alpha • 1d ago

Cadre Holdings: A Risky M&A Strategy Worth Betting On

Seeking Alpha report covering Cadre Holdings Inc. (CDRE) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Moomoo • 1d ago

Cadre Holdings(CDRE) Stock Options Chain | Quotes & News

Moomoo report covering Cadre Holdings Inc. (CDRE) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Yahoo Finance • 1d ago

Cadre Holdings Declares Quarterly Dividend of $0.10 Per Share

Yahoo Finance report covering Cadre Holdings Inc. (CDRE) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE MarketBeat • 1d ago

Cadre (CDRE) Stock Price, News & Analysis

MarketBeat report covering Cadre Holdings Inc. (CDRE) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE StockStory • 1d ago

2 Small-Cap Stocks Worth Investigating and 1 Facing Challenges

StockStory report covering Cadre Holdings Inc. (CDRE) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🔴 RISK WATCH Stock Traders Daily • 1d ago

Precision Trading with Cadre Holdings Inc. (CDRE) Risk Zones

Stock Traders Daily report covering Cadre Holdings Inc. (CDRE) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE https://www.siam.in/ • 1d ago

Cadre Holdings (CDRE) Slips 1.96% to $24.48, Drifting Toward Mid-Range Support - Last Point Resistance

https://www.siam.in/ report covering Cadre Holdings Inc. (CDRE) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

CDRE Bull vs. Bear Conversation Board — What's Your Call at $31.51?

🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON CDRE 🐻 33% BEARISH CONVICTION

TA TapeReader_Pro RQD DEBATE OPENER • Price Action & Volume Trader 🐂 BULLISH 🎯 Target: $40.08 (+32.0%)

📌 Pinned Debate

Strong cash engine and balance sheet: 11% ROIC, 4.27% FCF yield, Piotroski F 9/9, and Altman Z 3.32 support the quality case.

Long CDRE at $30.36 targeting $40.08. Strong cash engine and balance sheet: 11% ROIC, 4.27% FCF yield, Piotroski F 9/9, and Altman Z 3.32 support the quality case.. Institutional whale score is 10/20 and the risk/reward vs. the $24.07 52-week low is skewed heavily in favor of bulls.

VolSurface_Trader 🐂 BULL

Both sides have a point here — CDRE's 15/20 balance sheet score keeps downside contained, so the real swing factor next earnings call is backlog and FCF conversion.

SH ShortSeller_Dan RQD DEBATE OPENER • Forensic Short Bias 🐻 BEARISH 🎯 Target: $24.90 (-18.0%)

Spot @ $30.36

Elevated valuation and market sensitivity: P/E (TTM) of 30.2 with Beta 1.0 and a 7/20 Macro Regime Fit leave the stock exposed to multi

Sitting on the sidelines or leaning short CDRE above $30.36. Elevated valuation and market sensitivity: P/E (TTM) of 30.2 with Beta 1.0 and a 7/20 Macro Regime Fit leave the stock exposed to multiple compression.. Until Fundamental Cash Engine (16/20) and FCF yield (4.27%) inflect higher, upside is capped near $48.76.